NeuroMetrix (NURO) Competitors $3.90 0.00 (0.00%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NURO vs. BSGM, IRIX, FEMY, CODX, DRIO, VVOS, ALUR, MBOT, NRXS, and NEPHShould you be buying NeuroMetrix stock or one of its competitors? The main competitors of NeuroMetrix include BioSig Technologies (BSGM), IRIDEX (IRIX), Femasys (FEMY), Co-Diagnostics (CODX), DarioHealth (DRIO), Vivos Therapeutics (VVOS), Allurion Technologies (ALUR), Microbot Medical (MBOT), NeurAxis (NRXS), and Nephros (NEPH). These companies are all part of the "medical equipment" industry. NeuroMetrix vs. BioSig Technologies IRIDEX Femasys Co-Diagnostics DarioHealth Vivos Therapeutics Allurion Technologies Microbot Medical NeurAxis Nephros BioSig Technologies (NASDAQ:BSGM) and NeuroMetrix (NASDAQ:NURO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, community ranking, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment. Which has preferable earnings & valuation, BSGM or NURO? NeuroMetrix has higher revenue and earnings than BioSig Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioSig Technologies$39K592.18-$29.04MN/AN/ANeuroMetrix$3.77M2.11-$6.53M-$4.59-0.85 Do institutionals and insiders believe in BSGM or NURO? 7.2% of BioSig Technologies shares are owned by institutional investors. Comparatively, 19.4% of NeuroMetrix shares are owned by institutional investors. 17.0% of BioSig Technologies shares are owned by company insiders. Comparatively, 7.3% of NeuroMetrix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in BSGM or NURO? NeuroMetrix received 181 more outperform votes than BioSig Technologies when rated by MarketBeat users. However, 70.55% of users gave BioSig Technologies an outperform vote while only 58.32% of users gave NeuroMetrix an outperform vote. CompanyUnderperformOutperformBioSig TechnologiesOutperform Votes10370.55% Underperform Votes4329.45% NeuroMetrixOutperform Votes28458.32% Underperform Votes20341.68% Is BSGM or NURO more profitable? NeuroMetrix has a net margin of -203.71% compared to BioSig Technologies' net margin of -44,832.50%. BioSig Technologies' return on equity of 0.00% beat NeuroMetrix's return on equity.Company Net Margins Return on Equity Return on Assets BioSig Technologies-44,832.50% N/A -776.49% NeuroMetrix -203.71%-42.56%-39.26% Do analysts recommend BSGM or NURO? BioSig Technologies currently has a consensus price target of $2.75, suggesting a potential upside of 105.22%. Given BioSig Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe BioSig Technologies is more favorable than NeuroMetrix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioSig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NeuroMetrix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, BSGM or NURO? BioSig Technologies has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500. Comparatively, NeuroMetrix has a beta of 2.18, meaning that its share price is 118% more volatile than the S&P 500. Does the media refer more to BSGM or NURO? In the previous week, NeuroMetrix had 11 more articles in the media than BioSig Technologies. MarketBeat recorded 11 mentions for NeuroMetrix and 0 mentions for BioSig Technologies. NeuroMetrix's average media sentiment score of 0.64 beat BioSig Technologies' score of 0.00 indicating that NeuroMetrix is being referred to more favorably in the news media. Company Overall Sentiment BioSig Technologies Neutral NeuroMetrix Positive SummaryNeuroMetrix beats BioSig Technologies on 9 of the 16 factors compared between the two stocks. Ad Porter & CompanyVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Get NeuroMetrix News Delivered to You Automatically Sign up to receive the latest news and ratings for NURO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NURO vs. The Competition Export to ExcelMetricNeuroMetrixSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.97M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-0.8525.0189.7417.16Price / Sales2.1145.901,117.09117.04Price / CashN/A43.4443.1037.86Price / Book0.307.094.784.78Net Income-$6.53M$13.64M$120.31M$225.60M7 Day Performance2.42%-2.93%-1.92%-1.23%1 Month Performance-8.24%-1.42%13.65%0.46%1 Year Performance9.86%39.20%28.34%15.24% NeuroMetrix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NURONeuroMetrix0.7886 of 5 stars$3.90flatN/A+16.4%$7.97M$3.77M-0.8520Gap DownBSGMBioSig Technologies1.2149 of 5 stars$1.64+11.6%$2.75+67.7%-67.3%$28.27M$39,000.000.0050IRIXIRIDEX0.3474 of 5 stars$1.68-2.3%$2.00+19.0%-37.3%$27.95M$48.43M-2.57120Analyst ForecastNews CoverageFEMYFemasys2.1386 of 5 stars$1.18-1.1%$10.00+749.5%+22.6%$26.96M$1.26M-1.4730CODXCo-Diagnostics3.8295 of 5 stars$0.78-6.2%$1.50+92.3%-39.7%$24.91M$7.32M-0.60100DRIODarioHealth2.2551 of 5 stars$0.73-0.2%$4.00+447.6%-51.2%$24.90M$23.05M-0.78200News CoveragePositive NewsVVOSVivos Therapeutics2.8401 of 5 stars$5.08+10.2%$6.30+24.0%-57.7%$24.59M$13.80M-0.81160Positive NewsGap UpALURAllurion Technologies2.0377 of 5 stars$0.32-6.1%$2.88+786.0%-90.2%$20.89M$34.75M-0.67501Gap UpMBOTMicrobot Medical2.6578 of 5 stars$1.01+0.9%$7.00+593.5%-29.2%$17.09MN/A-1.2520NRXSNeurAxisN/A$2.43-2.0%N/A+5.3%$16.96M$2.46M-1.3519Gap DownNEPHNephros1.6925 of 5 stars$1.54-0.6%$5.00+224.7%-47.6%$16.24M$13.55M-17.2230Positive News Related Companies and Tools Related Companies BioSig Technologies Competitors IRIDEX Competitors Femasys Competitors Co-Diagnostics Competitors DarioHealth Competitors Vivos Therapeutics Competitors Allurion Technologies Competitors Microbot Medical Competitors NeurAxis Competitors Nephros Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NURO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroMetrix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroMetrix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NURO Stock Alerts